🟢 Neuroone Medical Technologies is trading 11.1% up today after OneRF study found 14 of 15 pain-free

Neuroone Medical Technologies is trading 11.1% higher at $0.95 after a peer-reviewed OneRF study found 14 of 15 patients immediately pain-free.

• The company announced the findings on October 29, 2026; all 15 patients had favorable outcomes at a mean six-month follow-up.
• The study was retrospective and small; larger studies are needed to assess durability and comparative effectiveness.
• Broader markets were weaker, making market-wide sentiment a less likely explanation.